Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC nicotine replacement therapy used in 5.8 mil. quit attempts a year -- SmithKline study.

This article was originally published in The Tan Sheet

Executive Summary

OTC NICOTINE REPLACEMENT THERAPY PART OF 5.8 MIL. 1997 QUIT ATTEMPTS in the U.S., according to estimates in study by Saul Shiffman, PhD, University of Pittsburgh, and SmithKline Beecham researchers published in the most recent issue of Tobacco Control, an independent quarterly journal. The estimate is based on extrapolation of A.C. Nielsen data from March through May 1997 showing 112,000 new purchases per week of SmithKline's Nicorette gum and NicoDerm CQ patch and McNeil Consumer Products' Nicotrol patch.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088240

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel